Mirjam Schenk (M Schenk)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Immune Response

Toll Like Receptor

Top Venues

Journal of internal medicine

Nature communications

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Sidar Aydin, Javier Pareja, Vivianne M Schallenberg, Armelle Klopstein, Thomas Gruber, Nicolas Page, Elisa Bouillet, Nicolas Blanchard, Roland Liblau, Jakob Körbelin, Markus Schwaninger, Aaron J Johnson, Mirjam Schenk, Urban Deutsch, Doron Merkler, Britta Engelhardt
Antigen recognition detains CD8 + T cells at the blood-brain barrier and contributes to its breakdown. Nature communications 14 (1) (2023)
Mirela Kremenovic, Alfred A Chan, Bing Feng, Lukas Bäriswyl, Steve Robatel, Thomas Gruber, Li Tang, Delphine J Lee, Mirjam Schenk
BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma. Journal for immunotherapy of cancer 10 (6) (2022)
Ivanina Mutisheva, Steve Robatel, Lukas Bäriswyl, Mirjam Schenk
An Innovative Approach to Tissue Processing and Cell Sorting of Fixed Cells for Subsequent Single-Cell RNA Sequencing. International journal of molecular sciences 23 (18) (2022)
Steve Robatel, Mirjam Schenk
Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment. Cancers 14 (4) (2022)
Thomas Gruber, Steve Robatel, Mirela Kremenovic, Lukas Bäriswyl, Jürg Gertsch, Mirjam Schenk
Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma. Cancers 13 (8) (2021)
Mirela Kremenovic, Mirjam Schenk, Delphine J Lee
Clinical and molecular insights into BCG immunotherapy for melanoma. Journal of internal medicine 288 (6) (2020)